Vascular Laser and Light Treatments

  • Brent C. Martin
  • Kristen M. KellyEmail author


This chapter provides an overview of vascular targeting light treatments applied to treatment of commonly encountered cutaneous vascular lesions, specifically port wine birthmarks (PWBs), infantile hemangiomas (IHs), and telangiectasias. Evidence-based recommendations are provided regarding light-based treatment effectiveness, preoperative evaluation, treatment techniques, safety, and postoperative management. We also discuss device and drug combinations which have been utilized including photodynamic therapy or laser in combination with antiangiogenic agents for PWBs and beta-blockers with lasers for IHs. This chapter provides a practical, concise, and evidence-based guide for the utilization of vascular-specific laser treatments available today.


Pulsed dye laser Nd:YAG Intense pulsed light (IPL) Alexandrite Port wine birthmarks/stains Infantile hemangiomas Telangiectasias 


  1. 1.
    Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–7.CrossRefGoogle Scholar
  2. 2.
    Alster TS, Wilson F. Treatment of port-wine stains with the flash lamp-pumped pulsed dye laser: extended clinical experience in children and adults. Ann Plast Surg. 1994;32:478–84.CrossRefGoogle Scholar
  3. 3.
    Lanigan SW. Lasers in dermatology. New York: Springer; 2000. Print.CrossRefGoogle Scholar
  4. 4.
    Hansen K, Kreiter CD, Rosenbaum M, et al. Long-term psychological impact and perceived efficacy of pulsed-dye laser therapy for patients with port-wine stains. Dermatol Surg. 2003;29:49.PubMedGoogle Scholar
  5. 5.
    McClean K, Hanke CW. The medical necessity for treatment of port-wine stains. Dermatol Surg. 1997;23:663.PubMedGoogle Scholar
  6. 6.
    Requena L, Sangueza OP. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol. 1997;37:887.CrossRefGoogle Scholar
  7. 7.
    Smolinski KN, Yan AC. Hemangiomas of infancy: clinical and biological characteristics. Clin Pediatr (Phila). 2005;44:747.CrossRefGoogle Scholar
  8. 8.
    Hare McCoppin HH, Goldberg DJ. Laser treatment of facial telangiectases: an update. Dermatol Surg. 2010;36:1221.CrossRefGoogle Scholar
  9. 9.
    Reyes BA, Geronemus R. Treatment of port-wine stains during childhood with the flashlamp-pumped pulsed dye laser. J Am Acad Dermatol. 1990;23:1142.CrossRefGoogle Scholar
  10. 10.
    Orten SS, Waner M, Flock S, et al. Port-wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. 1996;122:1174.CrossRefGoogle Scholar
  11. 11.
    Fiskerstrand EJ, Svaasand LO, Kopstad G, et al. Laser treatment of port wine stains: therapeutic outcome in relation to morphological parameters. Br J Dermatol. 1996;134:1039.CrossRefGoogle Scholar
  12. 12.
    Alster TS, Wilson F. Treatment of port-wine stains with the flashlamp-pumped pulsed dye laser: extended clinical experience in children and adults. Ann Plast Surg. 1994;32:478.CrossRefGoogle Scholar
  13. 13.
    Nguyen CM, Yohn JJ, Huff C, et al. Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye (585 nm) laser. Br J Dermatol. 1998;138:821–5. PMID: 9666828.CrossRefGoogle Scholar
  14. 14.
    Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: a few of 49 cases. Lasers Surg Med. 2007;39:563–8.CrossRefGoogle Scholar
  15. 15.
    Van der Horst CM, Koster PH, de Borgie CA, et al. Effect of the timing of treatment of port-wine stains with the flash-lamp-pumped pulsed-dye laser. N Engl J Med. 1998;338(15):1028–33.CrossRefGoogle Scholar
  16. 16.
    Reyes BA, Geronemus R. Treatment of port-wine stains during childhood with the flashlamp-pumped pulsed dye laser. J Am Acad Dermatol. 1990;23(6):1142–8.CrossRefGoogle Scholar
  17. 17.
    Goldman MP, Fitzpatrick RE, Ruiz-Esparza J. Treatment of port-wine stains (capillary malformation) with the flashlamp-pumped pulsed dye laser. J Pediatr. 1993;122(1):71–7.CrossRefGoogle Scholar
  18. 18.
    Ashinoff R, Geronemus RG. Flashlamp-pumped pulsed dye laser for port-wine stains in infancy: earlier versus later treatment. J Am Acad Dermatol. 1991;24(3):467–72.CrossRefGoogle Scholar
  19. 19.
    Onizuka K, Tsuneda K, Shibata Y, et al. Efficacy of flashlamp-pumped pulsed dye laser therapy for port wine stains: clinical assessment and histopathological characteristics. Br J Plast Surg. 1995;48:271.CrossRefGoogle Scholar
  20. 20.
    Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol. 1993;129:182.CrossRefGoogle Scholar
  21. 21.
    Garden JM, Polla LL, Tan OT. The treatment of port-wine stains by the pulsed dye laser. Analysis of pulse duration and long-term therapy. Arch Dermatol. 1988;124:889.CrossRefGoogle Scholar
  22. 22.
    Huikeshoven M, Koster PH, de Borgie CA, et al. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med. 2007;356:1235.CrossRefGoogle Scholar
  23. 23.
    Rizzo C, Brightman L, Chapas AM, et al. Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: a retrospective chart analysis. Dermatol Surg. 2009;35:1947.CrossRefGoogle Scholar
  24. 24.
    Poetke M, Philipp C, Berlien HP. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol. 2000;136:628.CrossRefGoogle Scholar
  25. 25.
    David LR, Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003;56:317.CrossRefGoogle Scholar
  26. 26.
    Reddy KK, Blei F, Brauer JA, et al. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol Surg. 2013;39:923.CrossRefGoogle Scholar
  27. 27.
    Iyer S, Fitzpatrick RE. Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes. Dermatol Surg. 2005;31:898.CrossRefGoogle Scholar
  28. 28.
    Alam M, Dover JS, Arndt KA. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg. 2003;29:681.PubMedGoogle Scholar
  29. 29.
    Madan V, Ferguson F. Using the ultra-long pulse width pulsed dye laser and elliptical spot to treat resistant nasal telangiectasia. Lasers Med Sci. 2010;25:151–15.CrossRefGoogle Scholar
  30. 30.
    Gaitan S, et al. Anesthesia methods in laser resurfacing. Semin Plast Surg. 2012;26(3):117–24.CrossRefGoogle Scholar
  31. 31.
    Pay AD, Kenealy J. The use of nerve blocks in the laser treatment of cutaneous lesions. Br J Plast Surg. 1997;50(2):132–4.CrossRefGoogle Scholar
  32. 32.
    Cunningham BB, Gigler V, Wang K, et al. General anesthesia for pediatric dermatologic procedures: risks and complications. Arch Dermatol. 2005;141:573.CrossRefGoogle Scholar
  33. 33.
    Keenan RL, Shapiro JH, Dawson K. Frequency of anesthetic cardiac arrests in infants: effect of pediatric anesthesiologists. J Clin Anesth. 1991;3:433–7.CrossRefGoogle Scholar
  34. 34.
    Vespasiano M, Finkelstein M, Kurachek S. Propofol sedation: intensivists’ experience with 7304 cases in a children’s hospital. Pediatrics. 2007;120(6):e1411–7.CrossRefGoogle Scholar
  35. 35.
  36. 36.
    Glatz P, Sandin RH, Pedersen NL, Bonamy A, Eriksson LI, Granath F. Association of Anesthesia and Surgery during Childhood with Long-term Academic Performance. JAMA Pediatr. Published online November 07, 2016e163470.
  37. 37.
    Davidson AJ, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. Lancet. 2016;387(10015):239–50.CrossRefGoogle Scholar
  38. 38.
    Kelly KM, Choi B, McFarlane S, et al. Description and analysis of treatments for port-wine stain birthmarks. Arch Facial Plast Surg. 2005;7:287.CrossRefGoogle Scholar
  39. 39.
    Cantatore JL, Kriegel DA. Laser surgery: an approach to the pediatric patient. J Am Acad Dermatol. 2004;50:165.CrossRefGoogle Scholar
  40. 40.
    Pence B, Aybey B, Ergenekon G. Outcomes of 532 nm frequency-doubled Nd:YAG laser use in the treatment of port-wine stains. Dermatol Surg. 2005;31(5):509–17.CrossRefGoogle Scholar
  41. 41.
    Chowdhury MM, Harris S, Lanigan SW. Potassium titanyl phosphate laser treatment of resistant port-wine stains. Br J Dermatol. 2001;144:814.CrossRefGoogle Scholar
  42. 42.
    Tierney EP, Hanke CW. Alexandrite laser for the treatment of port wine stains refractory to pulsed dye laser. Dermatol Surg. 2011;37:1268.CrossRefGoogle Scholar
  43. 43.
    Izikson L, Nelson J, Anderson R. Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients. Lasers Surg Med. 2009;41(6):427–32.CrossRefGoogle Scholar
  44. 44.
    Izikson L, Anderson RR. Treatment endpoints for resistant port wine stains with a 755 nm laser. J Cosmet Laser Ther. 2009;11:52.CrossRefGoogle Scholar
  45. 45.
    Van Drooge AM, et al. Long-pulsed 1064 nm Nd:YAG laser improves hypertrophic port-wine stains. J Eur Acad Dermatol Venereol. 2013;27(11):1381–6.CrossRefGoogle Scholar
  46. 46.
    Faurschou A, Togsverd-Bo K, Zachariae C, Haedersdal M. Pulsed dye laser vs. intense pulsed light for port-wine stains: a randomized side-by-side trial with blinded response evaluation. Br J Dermatol. 2009;160(2):359–64.CrossRefGoogle Scholar
  47. 47.
    Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for the treatment of dye laser resistant port-wine stains. J Cosmet Laser Ther. 2003;5:7.PubMedGoogle Scholar
  48. 48.
    Anolik R, Newlove T, Weiss ET, et al. Investigation into optimal treatment intervals of facial port-wine stains using the pulsed dye laser. J Am Acad Dermatol. 2012;67:985.CrossRefGoogle Scholar
  49. 49.
    Tanghetti E, Sherr EA, Sierra R, Mirkov M. The effects of pulse dye laser double-pass treatment intervals on depth of vessel coagulation. Lasers Surg Med. 2006;38:16.CrossRefGoogle Scholar
  50. 50.
    Raulin C, Greve B. Retrospective clinical comparison of hemangioma treatment by flashlamp-pumped (585 nm) and frequency-doubled Nd:YAG (532 nm) lasers. Lasers Surg Med. 2001;28:40.CrossRefGoogle Scholar
  51. 51.
    Tanghetti EA, Sherr E, Sierra R, Mirkov M. Sequential 595 nm, 1064 nm laser treatment for blebbed portwine stains and leg veins [abstract]. Lasers Surg Med. 2005;36:74.Google Scholar
  52. 52.
    Blankenship CM, Alster TS. Fractional photothermolysis of residual hemangioma. Dermatol Surg. 2008;34:1112.PubMedGoogle Scholar
  53. 53.
    Brightman LA, Brauer JA, Terushkin V, et al. Ablative fractional resurfacing for involuted hemangioma residuum. Arch Dermatol. 2012;148:1294.CrossRefGoogle Scholar
  54. 54.
    Rohrer TE, Chatrath V, Iyengar V. Does pulse stacking improve the results of treatment with variable-pulse pulsed-dye lasers? Dermatol Surg. 2004;30:163.PubMedGoogle Scholar
  55. 55.
    Cassuto DA, Ancona DM, Emanuelli G. Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm. J Cutan Laser Ther. 2000;2:141–6.CrossRefGoogle Scholar
  56. 56.
    Clementoni MT, Gilardino P, Muti GF, et al. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med. 2005;37:9.CrossRefGoogle Scholar
  57. 57.
    Major A, Brazzini B, Campolmi P, Bonan P, Mavilia L, Ghersetich I, Hercogova J, Lotti T. Nd:YAG 1064 nm laser in the treatment of facial and leg telangiectasias. J Eur Acad Dermatol Venereol. 2001;15:559–65. Scholar
  58. 58.
    Tremaine AM, Avram MM. FDA MAUDE data on complications with lasers, light sources, and energy-based devices. Lasers Surg Med. 2015;47(2):133–40.CrossRefGoogle Scholar
  59. 59.
    Seukeran DC, Collins P, Sheehan-Dare RA. Adverse reactions following pulsed tunable dye laser treatment of port wine stains in 701 patients. Br J Dermatol. 1997;136:725–9. PMID 9205506.CrossRefGoogle Scholar
  60. 60.
    Witman PM, Wagner AM, Scherer K, et al. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med. 2006;38:116.CrossRefGoogle Scholar
  61. 61.
    Gao K, Huang Z, Yuan KH, et al. Side-by-side comparison of photodynamic therapy and pulsed-dye laser treatment of port-wine stain birthmarks. Br J Dermatol. 2013;168(5):1040–6.CrossRefGoogle Scholar
  62. 62.
    Qin ZP, Li KL, Ren L, Liu XJ. Photodynamic therapy of port wine stains – a report of 238 cases. Photodiagnosis Photodyn Ther. 2007;4:53–9.CrossRefGoogle Scholar
  63. 63.
    Yuan KH, Li Q, Yu WL, et al. Comparison of photodynamic therapy and pulsed dye laser in patients with port wine stain birthmarks: a retrospective analysis. Photodiagn Photodyn Ther. 2008;5:50.CrossRefGoogle Scholar
  64. 64.
    Tournas JA, Lai J, Truitt A, et al. Combined benzoporphyrin derivative monoacid ring photodynamic therapy and pulsed dye laser for port wine stain birthmarks. Photodiagn Photodyn Ther. 2009;6:195.CrossRefGoogle Scholar
  65. 65.
    Yuan KH, Li Q, Yu WL, Huang Z. Photodynamic therapy in treatment of port wine stain birthmarks--recent progress. Photodiagn Photodyn Ther. 2009;6:189.CrossRefGoogle Scholar
  66. 66.
    Marques L, et al. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformation in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial. J Am Acad Dermatol. 2015;72(1):151–8.CrossRefGoogle Scholar
  67. 67.
    Gao L, et al. Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways. Lasers Surg Med. 2014;46(9):679–88.CrossRefGoogle Scholar
  68. 68.
    Chinnadurai S, Fonnesbeck C, Snyder KM, Sathe NA, Morad A, Likis FE, McPheeters ML. Pharmacologic interventions for infantile hemangioma: a meta-analysis. Pediatrics. 2016;137(2):1–10.CrossRefGoogle Scholar
  69. 69.
    Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.CrossRefGoogle Scholar
  70. 70.
    Chan H, et al. RCT of timolol maleate gel for superficial infantile hemangiomas in 5-to 24-week-olds. Pediatrics. 2013;131(6):e1739–47.CrossRefGoogle Scholar
  71. 71.
    Abarzúa-Araya Á, et al. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. J Am Acad Dermatol. 2014;70(6):1045–9.CrossRefGoogle Scholar
  72. 72.
    Reddy KK, et al. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol Surg. 2013;39(6):923–33.CrossRefGoogle Scholar
  73. 73.
    Asilian A, Mokhtari F, Kamali AS, Abtahi-Naeini B, Nilforoushzadeh MA, Mostafaie S. Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: a double-blind randomized controlled trial. Adv Biomed Res. 2015;4:257.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of CaliforniaIrvineUSA
  2. 2.Departments of Dermatology and SurgeryUniversity of CaliforniaIrvineUSA

Personalised recommendations